Impilo

Qufora is a medical device company focused on developing solutions for individuals with chronic bowel disorders. The company specializes in products that facilitate bowel irrigation and address issues such as chronic constipation and fecal incontinence. By providing innovative medical irrigation solutions, Qufora aims to improve the quality of life for those suffering from these conditions.

Immedica is a fast-growing private niche pharma group. Its headquarter is based in Stockholm, Sweden, and it has commercial coverage across Europe and the Middle East. Immedica provides significant know-how and experience from the commercialization of niche/specialty care products across Europe and the Middle East, and the company’s management team has an outstanding track record of operating niche pharma products internationally. Immedica has capabilities to provide optimal access to specialty care medicines to patients with significant medical needs, including key areas such as regulatory affairs, pharmacovigilance, medical affairs, pricing & reimbursement, quality, and product distribution. Immedica’s main owner is Impilo AB, a private Nordic investment company established in 2017, with more than SEK 3.6 billion in committed capital from leading Nordic and international investors.

VaccineDirect offers vaccinations, travel advice, health checks, and tests, issues medical and health certificates and provides services for infants and adults. The contact mode is by mail, phone, and physical address.

Pelago Bioscience specializes in drug discovery through its innovative Cellular Thermal Shift Assay technology. This approach facilitates target engagement studies that analyze how drug candidates interact with specific target proteins within cells and tissues. By providing more relevant data for drug delivery, the company's technology enhances the ability to filter compounds based on physiologically relevant information. This capability aids in bridging the gap between laboratory research and clinical application, ultimately leading to the faster and more effective development of new and improved therapeutics.

Decon is a manufacturer and supplier of medical equipment as well as accessories for all types of wheelchairs in the market.

Scantox is a contract research organization located in Lille Skensved, Denmark, specializing in pharmacology and regulatory toxicology services. The company provides preclinical research services tailored for the pharmaceutical and medical device industries, assisting clients in advancing their drug or device development with reliable data that meets technical and scientific standards. Scantox offers a range of services, including safety pharmacology, exploratory testing, and endotoxin testing, ensuring comprehensive support throughout the product development process.

Cavidi is Sweden’s leading supplier of viral load for HIV monitoring. Cavidi’s products enable efficient management of anti-HIV drugs (ARV therapy) so that people living with HIV can live a normal lifespan. Cavidi’s diagnostics reduce the cost of treatment and the spread of HIV. Cavidi also provides tools and kits for virus research to many of the world’s leading labs. Cavidi is a Swedish biotech company founded as a spin-off from Uppsala University. Their expertise is based on understanding viruses and using this knowledge to create research tools and clinical diagnostics. Today their focus is on HIV but our methods and expertise can be applied to other viruses. Cavidi’s head office is in Uppsala, Sweden and they have sales offices in South Africa, India and USA. Their customers include hospitals, patient clinics, private laboratories, the pharmaceutical industry and research institutions worldwide.